- Home
- AKRO vs SBET Comparison
AKRO vs SBET Comparison
Compare AKRO & SBET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- SBET
- Stock Information
- Founded
- AKRO 2017
- SBET 1995
- Country
- AKRO United States
- SBET United States
- Employees
- AKRO N/A
- SBET N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- SBET Computer Software: Prepackaged Software
- Sector
- AKRO Health Care
- SBET Technology
- Exchange
- AKRO Nasdaq
- SBET Nasdaq
- Market Cap
- AKRO 3.6B
- SBET 3.2B
- IPO Year
- AKRO 2019
- SBET 1997
- Fundamental
- Price
- AKRO $46.27
- SBET $17.36
- Analyst Decision
- AKRO Strong Buy
- SBET
- Analyst Count
- AKRO 8
- SBET 0
- Target Price
- AKRO $80.38
- SBET N/A
- AVG Volume (30 Days)
- AKRO 915.6K
- SBET 29.3M
- Earning Date
- AKRO 11-07-2025
- SBET 11-14-2025
- Dividend Yield
- AKRO N/A
- SBET N/A
- EPS Growth
- AKRO N/A
- SBET N/A
- EPS
- AKRO N/A
- SBET N/A
- Revenue
- AKRO N/A
- SBET $3,144,153.00
- Revenue This Year
- AKRO N/A
- SBET $858.54
- Revenue Next Year
- AKRO N/A
- SBET $194.83
- P/E Ratio
- AKRO N/A
- SBET N/A
- Revenue Growth
- AKRO N/A
- SBET N/A
- 52 Week Low
- AKRO $21.34
- SBET $2.26
- 52 Week High
- AKRO $58.40
- SBET $124.12
- Technical
- Relative Strength Index (RSI)
- AKRO 51.29
- SBET 48.03
- Support Level
- AKRO $41.80
- SBET $16.19
- Resistance Level
- AKRO $45.44
- SBET $17.83
- Average True Range (ATR)
- AKRO 1.97
- SBET 1.15
- MACD
- AKRO 0.06
- SBET 0.21
- Stochastic Oscillator
- AKRO 75.76
- SBET 75.39
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About SBET SharpLink Gaming Ltd.
SharpLink Gaming Inc is a online technology company that connects sports fans, leagues and sports websites to relevant and timely sports betting content. The company owns a performance marketing platform through which the company owns and operates state-specific web domains designed to attract, acquire, and drive local sports betting and casino traffic directly to its sportsbook and casino partners which are licensed to operate in each respective state. The company has one operating segment: Affiliate Marketing Services, which operates in United States and Rest of the world. The company generates the majority of the revenue earned from the Affiliate Marketing Services in Rest of the world.